Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older
Clinical trial NCT05534035 · UNKNOWN
Trial details
- NCT number
- NCT05534035
- Sponsor
- Everest Medicines (Singapore) Pte. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-03
- Primary completion
- 2023-04-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.